- Home
- BIO vs CAVA Comparison
BIO vs CAVA Comparison
Compare BIO & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- CAVA
- Stock Information
- Founded
- BIO 1952
- CAVA 2006
- Country
- BIO United States
- CAVA United States
- Employees
- BIO N/A
- CAVA 8100
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- CAVA Restaurants
- Sector
- BIO Industrials
- CAVA Consumer Discretionary
- Exchange
- BIO Nasdaq
- CAVA Nasdaq
- Market Cap
- BIO 8.7B
- CAVA 13.9B
- IPO Year
- BIO N/A
- CAVA 2023
- Fundamental
- Price
- BIO $329.91
- CAVA $122.87
- Analyst Decision
- BIO Buy
- CAVA Buy
- Analyst Count
- BIO 4
- CAVA 13
- Target Price
- BIO $369.00
- CAVA $109.83
- AVG Volume (30 Days)
- BIO 209.2K
- CAVA 4.8M
- Earning Date
- BIO 10-24-2024
- CAVA 11-05-2024
- Dividend Yield
- BIO N/A
- CAVA N/A
- EPS Growth
- BIO N/A
- CAVA N/A
- EPS
- BIO N/A
- CAVA 0.38
- Revenue
- BIO $2,562,604,000.00
- CAVA $845,224,000.00
- Revenue This Year
- BIO N/A
- CAVA $30.85
- Revenue Next Year
- BIO $4.49
- CAVA $20.92
- P/E Ratio
- BIO N/A
- CAVA $327.30
- Revenue Growth
- BIO N/A
- CAVA 31.01
- 52 Week Low
- BIO $261.59
- CAVA $29.05
- 52 Week High
- BIO $377.88
- CAVA $128.18
- Technical
- Relative Strength Index (RSI)
- BIO 55.57
- CAVA 66.42
- Support Level
- BIO $311.04
- CAVA $113.13
- Resistance Level
- BIO $337.50
- CAVA $127.00
- Average True Range (ATR)
- BIO 8.93
- CAVA 4.61
- MACD
- BIO -0.74
- CAVA -0.00
- Stochastic Oscillator
- BIO 68.00
- CAVA 75.27
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.